Reactome | HAVCR2 binds LGALS9

HAVCR2 binds LGALS9

Stable Identifier

R-HSA-5340385

Type

Reaction [binding]

Species

Homo sapiens

Compartment

extracellular region, plasma membrane

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

T-helper (Th) cell-mediated immunity is required to eliminate pathogens effectively but unrestrained Th activity can contribute to tissue damage in many inflammatory and autoimmune diseases. The T-cell immunoglobulin and mucin domain-containing protein (HAVCR2, TIM3) inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and allo-immune responses and promotes immunological tolerance when it binds to its ligand, galectin-9 (LGALS9). The HAVCR2:LGALS9 complex achieves this inhibition by inducing apoptosis of Th1 cells. The human event is inferred from experimental data from mouse studies (Sanchez-Fueyo et al. 2003, Zhu et al. 2005).

Literature References

PubMed ID	Title	Journal	Year
14556005	Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance Gutiérrez-Ramos, JC, Kamradt, T, Sánchez-Fueyo, A, Picarella, D, Domenig, C, Sabatos, CA, Strom, TB, Bender, O, Tian, J, Coyle, AJ, Manlongat, N, Kuchroo, VK, Zheng, XX	Nat. Immunol.	2003
16286920	The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity Schubart, A, Khoury, SJ, Xiong, H, Strom, TB, Anderson, AC, Kuchroo, VK, Imitola, J, Zhu, C, Zheng, XX	Nat. Immunol.	2005